Hazard ratios from multivariate analysis of overall survival
Clinical predictor (hazard ratio comparison) . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Treatment, CALGB 9712 vs CALGB 9011 | 2.59 (1.50-4.46) | .0006 |
| WBC, 75th vs 25th percentile | 1.23 (1.05-1.44) | .009 |
| Age, 75th vs 25th percentile | 1.59 (1.18-1.93) | .001 |
| LDH, 75th vs 25th percentile | 1.18 (1.03-1.36) | .02 |
| Sex, male vs female | 1.25 (0.86-1.81) | .24 |
| Rai stage, high vs intermediate | 1.22 (0.88-1.69) | .23 |
| Splenomegaly, present vs absent | 1.20 (0.84-1.71) | .33 |
Clinical predictor (hazard ratio comparison) . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Treatment, CALGB 9712 vs CALGB 9011 | 2.59 (1.50-4.46) | .0006 |
| WBC, 75th vs 25th percentile | 1.23 (1.05-1.44) | .009 |
| Age, 75th vs 25th percentile | 1.59 (1.18-1.93) | .001 |
| LDH, 75th vs 25th percentile | 1.18 (1.03-1.36) | .02 |
| Sex, male vs female | 1.25 (0.86-1.81) | .24 |
| Rai stage, high vs intermediate | 1.22 (0.88-1.69) | .23 |
| Splenomegaly, present vs absent | 1.20 (0.84-1.71) | .33 |